Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.

about

Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.

Item

http://www.wikidata.org/entity/Q41922709

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Association between Haemagglut ...... e 6B viruses in 2013 and 2015.

@en

type

Item

label

Association between Haemagglut ...... e 6B viruses in 2013 and 2015.

@en

prefLabel

Association between Haemagglut ...... e 6B viruses in 2013 and 2015.

@en

P1476

Association between Haemagglut ...... e 6B viruses in 2013 and 2015.

@en

P2093

Nery Sanchez

http://www.w3.org/2001/XMLSchema#string

Saira Saborio

http://www.w3.org/2001/XMLSchema#string

Sergio Ojeda

http://www.w3.org/2001/XMLSchema#string

Sophia Ng

http://www.w3.org/2001/XMLSchema#string

P2860

Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

The Nicaraguan pediatric influenza cohort study: design, methods, use of technology, and compliance

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

Hospitalization Incidence, Mortality, and Seasonality of Common Respiratory Viruses Over a Period of 15 Years in a Developed Subtropical City

Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans

Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines.

Epitope mapping of the 2009 pandemic and the A/Brisbane/59/2007 seasonal (H1N1) influenza virus haemagglutinins using mAbs and escape mutants.

Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.

Advances in the development of influenza virus vaccines.

Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua.

P304

6202-6207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2017.09.036

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28986036

http://www.w3.org/2001/XMLSchema#string

P932

5685664

http://www.w3.org/2001/XMLSchema#string